Complete Wegovy vs Mounjaro Dosage Comparison Guide
Online Prescription Process for Wegovy vs Mounjaro Dosage Assessment
Getting prescribed Wegovy or Mounjaro online eliminates the traditional barriers of GP appointments and specialist referrals when comparing dosage options. Our 3-minute clinical assessment evaluates your BMI, medical history, current medications, and weight management goals to determine which treatment and starting dose suits your circumstances. The assessment covers contraindications specific to each medication - for instance, Wegovy's GLP-1 mechanism versus Mounjaro's dual GIP/GLP-1 action may influence prescriber recommendations based on your diabetes status or gastroparesis history.
Licensed UK prescribers review every wegovy vs mounjaro dosage chart request within 3 working days, with express 24-hour reviews available for urgent cases. Unlike high-street consultations, our online process allows you to compare both treatment pathways simultaneously, with detailed dosage explanations provided before you commit to either medication. This comprehensive approach ensures you understand the 20-week dose escalation journey for Wegovy versus Mounjaro's 12-week titration schedule before starting treatment.
Wegovy vs Mounjaro Dosage Chart: Pricing and Value Comparison
Understanding the cost implications of each wegovy vs mounjaro dosage chart helps inform your treatment decision alongside clinical factors. Wegovy follows a 5-step escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). Our Getting Started bundles simplify the initial phases - the Intro Duo covers weeks 1-8 for £169.99, whilst the Progress Duo handles weeks 5-12 for £189.99. New customers apply code FIRST40 at checkout, with returning customers using DOSE25.
Mounjaro pricing reflects its different dose schedule, though direct cost comparison depends on your prescribed maintenance dose and titration speed. Both medications require prescription-only access through licensed pharmacies, making online consultation fees and delivery charges important considerations. Our bundles provide convenience through Reliable Supply and single deliveries rather than multiple monthly orders, particularly valuable given the dose escalation requirements in both wegovy vs mounjaro dosage charts.
Clinical Evidence: Wegovy vs Mounjaro Dosage Chart Outcomes
The STEP trials demonstrated Wegovy's efficacy across its 5-dose escalation schedule, with patients achieving approximately 15% average weight loss at 68 weeks when following the complete dosage chart (Wilding et al., NEJM, 2021). The structured dose escalation from 0.25mg to 2.4mg maintenance appeared crucial for tolerability and sustained outcomes. STEP 5 confirmed that approximately clinically studied weight loss could be sustained at 2 years when patients adhered to the full wegovy dosage protocol.
Mounjaro's SURMOUNT trials evaluated its 4-step dose escalation, though direct comparison between wegovy vs mounjaro dosage chart outcomes requires careful interpretation due to different trial populations and endpoints. Both medications require adherence to their specific dose escalation schedules to optimise efficacy and minimise gastrointestinal side effects, making the dosage chart comparison particularly relevant for treatment planning.
How Wegovy Works Within Its Dosage Framework
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and gastric emptying. The wegovy vs mounjaro dosage chart comparison reveals that Wegovy's mechanism targets a single receptor pathway, requiring its specific 5-step escalation to achieve therapeutic levels whilst maintaining tolerability. Starting at 0.25mg allows patients to adapt to increased satiety signals and reduced appetite gradually. Each 4-week dose increase builds GLP-1 receptor activation until reaching the 2.4mg maintenance dose, where appetite suppression and delayed gastric emptying provide sustained weight management support. This once-weekly injection schedule, delivered via the FlexTouch pen system, maintains consistent semaglutide levels throughout the dosage escalation journey.
Ordering Process: Wegovy vs Mounjaro Dosage Chart Selection
Our streamlined ordering process accommodates both wegovy and mounjaro dosage chart requirements through a single clinical assessment platform. Complete the 3-minute evaluation covering your weight management history, medical conditions, and dosage preferences - this information helps prescribers determine whether Wegovy's 20-week escalation or Mounjaro's alternative schedule better suits your circumstances. Once approved, we dispatch your prescribed medication via next-day cold-chain delivery, maintaining the 2-8°C storage requirements essential for both treatments. The FlexTouch pen system for Wegovy and Mounjaro's delivery device are both included, with comprehensive injection technique guidance provided. Order tracking ensures you know exactly when your first dose arrives, allowing you to begin either dosage schedule with confidence.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Storage requirements differ subtly between treatments when comparing the wegovy vs mounjaro dosage chart logistics over time. Wegovy maintains stability for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit - this advantage proves valuable during travel or dosage transitions. Both medications require 2-8°C refrigerator storage before first use, with the FlexTouch pen systems designed for single-dose weekly injections. The wegovy dosage escalation from 0.25mg to 2.4mg spans 16 weeks, meaning you'll handle 5 different strength pens during titration, whilst Mounjaro's schedule involves fewer dose changes. Proper storage throughout the entire dosage chart journey ensures medication potency and injection comfort, particularly important during the initial escalation phases when side effect monitoring is crucial.
Online Prescription Advantages for Wegovy vs Mounjaro Dosage Planning
Accessing wegovy vs mounjaro dosage chart information through online prescription services eliminates the geographical and scheduling constraints of traditional weight management clinics. Our prescribers can review your complete medical history alongside current medications to identify potential interactions specific to each treatment's mechanism - crucial when comparing GLP-1-only versus dual incretin approaches. The online consultation documentation provides a permanent record of your dosage progression, medication tolerance, and any adjustments made during treatment.
Digital prescription management proves particularly valuable during dose escalation phases, allowing easy reordering and automatic reminders for your next strength increase. Unlike face-to-face consultations that may require weeks of advance booking, our online wegovy vs mounjaro dosage chart consultations adapt to your schedule and treatment timeline. This flexibility ensures continuity of care throughout the extended dose escalation periods required by both medications, supporting better adherence and outcomes.
Start Your Wegovy vs Mounjaro Dosage Journey Today
Ready to begin comparing wegovy vs mounjaro dosage charts through professional medical assessment? Complete our 3-minute clinical evaluation to receive personalised prescriber recommendations for either treatment pathway. New customers save with code FIRST40, whilst returning customers use DOSE25 - both applied at checkout for transparent pricing. Our licensed UK prescribers will review your assessment within 3 working days, providing detailed dosage guidance and treatment selection rationale. Visit https://everydaymeds.co.uk/collections/wegovy to access both treatment options through our secure online platform. As a prescription-only medicine, both Wegovy and Mounjaro require proper medical oversight - our GPhC-registered service (#9012878) ensures you receive this essential care alongside convenient access to these effective weight management treatments.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
